April 6-11, 1997
ISAR was created in 1987 to advance and disseminate knowledge in all areas of antiviral research. The society is a non-profit scientific organization with approximately 1,000 members representing 30 countries.
Generally, the presentations are on antiviral compounds not yet licensed for use or for licensed drugs at doses or indications not yet licensed. These reports cover a few selected HIV and HBV presentations. They are intended solely to give an account of those presentations and should not be inferred to give any recommendation for clinical usage.
These selected conference summations are reported exclusively for The Body by renowned researcher R. Anthony Vere Hodge, D. Phil. (Oxon.). Funding for this conference coverage at The Body is provided, in part, through an unrestricted educational grant by Bristol-Myers Squibb Immunology.